Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Publication Date: September 1, 2017
Last Updated: December 16, 2022
Treatment
In adults with active IBD treated with anti-TNF agents, AGA suggests reactive therapeutic drug monitoring to guide treatment changes.
Comment: Table 1 summarizes suggested trough concentration for anti-TNF therapy for patients with active IBD on maintenance therapy. Of note, there may be a small subset of patients who may respond to higher target concentrations. Optimal trough concentrations for induction therapy are uncertain.
612
Title
Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Authoring Organization
American Gastroenterological Association